Pharmabiz3d
QurAlis announces positive data from phase 1 trial of QRL-101 evaluating biomarkers of ALS and epilepsy in healthy volunteers
QRL-101-03 (NCT06532396) is a randomized, double-blind, placebo-controlled, multiple-ascending dose clinical trial evaluating the safety, tolerability, and PK of QRL-101 in up to 60 healthy ...
eLife6d
Minimal background noise enhances neural speech tracking: Evidence of stochastic resonance
This study presents an important contribution to the understanding of neural speech tracking, demonstrating how minimal background noise can enhance the neural tracking of the amplitude-onset envelope ...
Yahoo Finance2d
Amplitude, Inc. (AMPL)
As of 3:15:18 PM EDT. Market Open. Loading Chart for AMPL ...